The B.1.617.2 (delta) variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has contributed to a surge in cases in India and has now been detected across the globe, including a notable increase in cases in the United Kingdom. The effectiveness of the BNT162b2 and ChAdOx1 nCoV-19 vaccines against this variant has been unclear.

Matéria original

Antonio Carlos Bezerra, assume vaga de membro titular no Comitê Gestor da Farmacopeia Brasileira
Anterior

Antonio Carlos Bezerra, assume vaga de membro titular no Comitê Gestor da Farmacopeia Brasileira

Próxima

The virological impacts of SARS-CoV-2 D614G mutation